HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rodan, S. B. Articles by Rodan, G. A. Search for Related Content PubMed Articles by Rodan, S. B. Articles by Rodan, G. A.

A clonal cell line (Saos-2/B-10) derived from human osteosarcoma Saos-2 cells had the same osteoblastic characteristics as the mother line, but lacked sensitivity to parathyroid hormone (PTH) at early passages. At later passages (> 70) the cells became very sensitive to PTH (0·1 nmol/l). The absence of PTH-stimulatable adenylate cyclase correlated with the secretion of an adenylate cyclase-stimulatory activity which had the properties of the recently characterized PTH-like peptide (PTH-LP). This activity was inhibited by the PTH antagonist [⁸norleucyl, ¹⁸norleucyl, ³⁴tyrosinyl]bovine PTH-(3–34)amide and could be neutralized by an antiserum raised against the synthetic PTH-LP-(1–34). Hybridization with a human PTH-LP cDNA showed that these cells produce two PTH-LP mRNAs of approximately 1·5 and 1·8 kb. The production of PTH-LP was stimulated by 12-O-tetradecanoylphorbol-13-acetate (TPA; 150 nmol/l) and epidermal growth factor (EGF; 10 ng/ml). The increased accumulation of PTH-LP in conditioned media in response to TPA was seen after 1 h and levelled off at 6 h. In contrast, EGF stimulation was lower at 3 and 6 h but continued for 24 h. Both agents increased PTH-LP mRNA levels in Saos-2/B-10 cells. A TPA analogue which does not stimulate protein kinase C had no effect on PTH-LP production. Cycloheximide blocked the stimulatory effect of both TPA and EGF and the TPA effect was blocked by actinomycin D, suggesting transcriptional control. The regulation of PTH-LP by these agents may offer clues regarding the association of this protein with malignancy.

Journal of Endocrinology (1989) 122, 219–227

This article has been cited by other articles:

				N. Chattopadhyay Effects of calcium-sensing receptor on the secretion of parathyroid hormone-related peptide and its impact on humoral hypercalcemia of malignancy Am J Physiol Endocrinol Metab, May 1, 2006; 290(5): E761 - E770. [Abstract] [Full Text] [PDF]

				F. Aklilu, J. Gladu, D. Goltzman, and S. A. Rabbani Role of Mitogen-activated Protein Kinases in the Induction of Parathyroid Hormone-related Peptide Cancer Res., March 1, 2000; 60(6): 1753 - 1760. [Abstract] [Full Text]

				A. J. Koh, C. A. Beecher, T. J. Rosol, and L. K. McCauley 3',5'-Cyclic Adenosine Monophosphate Activation in Osteoblastic Cells: Effects on Parathyroid Hormone-1 Receptors and Osteoblastic Differentiation in Vitro Endocrinology, July 1, 1999; 140(7): 3154 - 3162. [Abstract] [Full Text]

				Y. Nishigaki, Y. Ohsaki, E. Toyoshima, and K. Kikuchi Increased Serum and Urinary Levels of a Parathyroid Hormone-related Protein COOH Terminus in Non-Small Cell Lung Cancer Patients Clin. Cancer Res., June 1, 1999; 5(6): 1473 - 1481. [Abstract] [Full Text] [PDF]

				A. T. Zhou, R. Bessalle, A. Bisello, C. Nakamoto, M. Rosenblatt, L. J. Suva, and M. Chorev Direct mapping of an agonist-binding domain within the parathyroid hormone/parathyroid hormone-related protein receptor by photoaffinity crosslinking PNAS, April 15, 1997; 94(8): 3644 - 3649. [Abstract] [Full Text] [PDF]